1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Carlsmed, Inc.

Carlsmed, Inc.

CARL
Carlsmed, Inc.US flagNASDAQ
12.29
USD
+0.95
- -
334.10MMarket Cap
Carlsmed, Inc.
CARL
(NASDAQ)

Recent

price

12.29

P/E

ratio

- -

div

yld

- -

ROIC.AI

2023
2024
2025
TTM
FRC
3.1
6.68
3.55
2.85
Revenue per Share
-4.25
-6.11
-2.12
-1.65
Basic EPS, GAAP
-3.96
-6.31
-2.08
-1.74
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
-10.55
-17.5
-7.09
-5.54
Book Value per Share
-10.38
-17.37
6.95
4.66
Tangible Book Value per Share
4
4
14
20
Basic Weighted Avg Shares
14
27
51
56
Sales/Revenue/Turnover
-134.93
-88.8
-60.53
-60.48
Operating Margin (%)
- -
- -
- -
- -
Depreciation Expense
-19
-24
-30
-33
Net Income, GAAP
- -
- -
- -
- -
Effective Tax Rate (%)
-137.16
-89.3
-58.67
-57.76
Profit Margin (%)
4
41
112
106
Working Capital
9
17
17
16
LT Debt
-46
-71
99
92
Total Equity
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1
1
1
LT Borrowings
15
15
15
LT Finance Leases
2
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
27
27
27
Market Capitalization
233
243
179

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
131
127
115
Cash, Cash Equivalents & STI
115
110
97
Accounts Receivable, Net
11
11
12
Inventories
1
2
2
Total Current Liabilities
11
14
10
Payables & Accruals
6
8
6
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-239.98%
Free Cash Flow
- -
- -
15.49%
Net Income, GAAP
- -
- -
22.17%
Sales/Revenue/Turnover
- -
- -
85.94%
Total Cash Common Dividend
- -
- -
-1.35%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5
6
7
9
27
2025
10
12
13
15
51
2026
16
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-1.19
-1.37
-1.83
- -
-6.11
2025
-0.24
-1.47
-0.4
-0.32
-2.12
2026
-0.32
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Surgical Innovations Group plc (SUN.L)
Shinhung Co., Ltd (004080.KS)
BrainsWay Ltd. (BWAY.TA)
Elbit Imaging Ltd. (EMITF-M.TA)
Nu-Med Plus, Inc. (NUMD)
InspireMD, Inc. (NSPR)
Business
<x<x

Company News

APIChatGPT

  • zacks.com

    Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?

  • seekingalpha.com

    Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

  • zacks.com

    Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet

  • seekingalpha.com

    Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript

  • zacks.com

    Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates

  • globenewswire.com

    Carlsmed® Reports First Quarter 2026 Financial Results

  • globenewswire.com

    Carlsmed, Inc. To Participate in Upcoming Investor Conferences

  • defenseworld.net

    Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf

  • globenewswire.com

    Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026

  • defenseworld.net

    Comparing MiniMed Group (NASDAQ:MMED) and Carlsmed (NASDAQ:CARL)

  • globenewswire.com

    Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference

  • defenseworld.net

    Financial Contrast: Carlsmed (NASDAQ:CARL) & Predictive Oncology (NASDAQ:AGPU)

  • defenseworld.net

    Contrasting Carlsmed (NASDAQ:CARL) and Medline (NASDAQ:MDLN)

  • defenseworld.net

    Head-To-Head Analysis: Carlsmed (NASDAQ:CARL) versus Predictive Oncology (NASDAQ:AGPU)

  • defenseworld.net

    Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference

  • defenseworld.net

    Critical Contrast: Carlsmed (NASDAQ:CARL) vs. Check-Cap (NASDAQ:MBAI)

  • seekingalpha.com

    Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript

  • globenewswire.com

    Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

  • globenewswire.com

    Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

  • defenseworld.net

    Head to Head Survey: Carlsmed (NASDAQ:CARL) & Check-Cap (NASDAQ:MBAI)